Recombinant protein of heptad-repeat HR212, a stable fusion inhibitor with potent anti-HIV action in vitro
文献类型：期刊论文
| 作者 | Pang W1,2,3; Wang RR2; Yang LM2; Liu CM1; Tien P[*]1; Zheng YT[*]2 |
| 刊名 | Virology
 |
| 出版日期 | 2008 |
| 卷号 | 377期号:1页码:80-87 |
| 关键词 | Anti-HIV agents proteinase K T20-resistant strains HR212 enfuvirtide fusion inhibitor HIV-1 HIV-2 |
| 通讯作者 | tienpo@sun.im.ac.cn ; zhengyt@mail.kiz.ac.cn |
| 合作状况 | 其它 |
| 英文摘要 | HR212, a recombinant protein expressed in Escherichia coli, has been previously reported to inhibit HIV-1 membrane fusion at low nanomolar level. Here we report that HR212 is effective in blocking laboratory strain HIV-1,B entry and replication with EC50 values of 3.92 +/- 0.62 and 6.59 +/- 1.74 nM, respectively, and inhibiting infection by clinic isolate HIV-1(KM018)with EC50 values of 44.44 +/- 10.20 nM, as well as suppressing HIV-1-induced cytopathic effect with an EC50 value of 3.04 +/- 1.20 nM. It also inhibited HIV-2(ROD) and HIV-2(CBL-20) entry and replication in the mu M range. Notably, HR212 was highly effective against T20-resistant strains with EC50 values ranging from 5.09 to 7.75 nM. Unlike T20, HR212 showed stability sufficient to inhibit syncytia formation in a time-of-addition assay, and was insensitive to proteinase K digestion These results suggest that HR212 has great potential to be further developed as novel HIV-1 fusion inhibitor for treatment of HIV/AIDS patients, particularly for those infected by T20-resistant variants. |
| 收录类别 | SCI |
| 资助信息 | This work was supported in part by grants from 863 Program (2006AA02A241) and the Outstanding Overseas Chinese Scholars Fund of the CAS for IMCAS, and from the CAS Program (KSCX1-YW-R-15, KSCX1-YW-R-24), 973 Program (2006CB504208, 2006CB504302), and Key Technological R&D Program of Yunnan (2004NG12) |
| 语种 | 英语 |
| 公开日期 | 2010-11-10 |
| 源URL | [http://159.226.149.42:8088/handle/152453/6435]  |
| 专题 | 昆明动物研究所_分子免疫药理学 昆明动物研究所_动物模型与人类重大疾病机理重点实验室 |
| 作者单位 | 1.Center for Molecular Virology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China 2.Laboratory of Molecular Immunopharmacology, Key Laboratory of Animal Models and Human Disease Mechanisms, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650223, China 3.Graduate School of the Chinese Academy of Sciences, Beijing 100039, China |
| 推荐引用方式 GB/T 7714 | Pang W,Wang RR,Yang LM,et al. Recombinant protein of heptad-repeat HR212, a stable fusion inhibitor with potent anti-HIV action in vitro[J]. Virology,2008,377(1):80-87. |
| APA | Pang W,Wang RR,Yang LM,Liu CM,Tien P[*],&Zheng YT[*].(2008).Recombinant protein of heptad-repeat HR212, a stable fusion inhibitor with potent anti-HIV action in vitro.Virology,377(1),80-87. |
| MLA | Pang W,et al."Recombinant protein of heptad-repeat HR212, a stable fusion inhibitor with potent anti-HIV action in vitro".Virology 377.1(2008):80-87. |
入库方式： OAI收割
来源：昆明动物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。